Our approach involved employing patient-specific organoid (PSO) models of CD276-positive ESCC PSO and CD276-negative adjacent epithelium PSO (NC PSO), primary culture of ESCC cells models, along with the KYSE-150 in vitro and in vivo models. Here, CD276 is linked to esophageal squamous cell carcinoma.